Martina C Cornel

Biographic Data

ID1249268
NAMEMartina C Cornel
GIVEN NAMESMartina C
FAMILY NAMECornel
SIGNATURECORNEL M C
AFFILIATIONSAmsterdam Public Health
ORCID0000-0002-5397-5544
VERIFIEDYes
TOTAL WORKS35
TOTAL CITATIONS11
AUTHOR COUNT35
EDITOR COUNT0
FIRST PUBLICATION YEAR1988
LATEST PUBLICATION YEAR2026
H-INDEX2

  • Dutch Christian Faith Leaders Deliberating Human Germline Gene Editing

    Open AccessWendy P Geuverink, Janneke T Gitsels et al.ARTICLEJournal of Religion and Health2026

    While human germline gene editing (HGGE) is not allowed, the World Health Organization and others called for public dialogue to clarify the values at stake. Some values may be rooted in religion, such as Christianity, and relevant to religious communities and wider society. In-depth interviews (N = 16) were conducted with Dutch Christian faith leaders in 2019 and 2024. Participants were asked about their views and underlying values, their possibl…

  • Personalised prevention

    Open AccessLoes Lindiwe Kreeftenberg, Lidewij Henneman et al.ARTICLEBMC Public Health2025

    Enhancing patient and public engagement in personalised prevention requires more focus on communication, inclusivity, and secure data use. The findings provide actionable insights, promoting systematic engagement across Research, Care, and Governance. Clear information about prevention strategies and treatment options must be accessible, while diverse voices should be represented in decision-making. Collaboration with communities and better use o…

  • The impact of counselors’ values and religious beliefs on their role identity and perspectives on heritable genome editing

    Open AccessWendy P Geuverink, Janneke Gitsels et al.ARTICLEHumanities and Social Sciences…2024

    The implementation of the noninvasive prenatal test has shown the importance of involving future care providers in healthcare innovations at an early stage. Therefore, in this explorative study in-depth interviews were performed with Dutch midwife counselors who explicitly identify as religious, to explore how they currently deal with their worldview during counseling for prenatal anomaly screening and regarding their perspectives on heritable ge…

  • Engagement of patients and the public in personalised prevention in Europe using genomic information

    Open AccessLoes Lindiwe Kreeftenberg, Lidewij Henneman et al.ARTICLEFrontiers in Public Health2024

    Introduction: Personalised prevention using genomic information requires active involvement from patients and the public, who should be well-informed and empowered to make healthcare decisions that reflect their personal values. We aimed to map engagement practises, and assess the extent and types of engagement methods used in the field of personalised prevention of common chronic conditions using genomic information. Methods: A scoping review on…

  • Between desire and fear

    Open AccessWendy P Geuverink, Carla van El et al.ARTICLEHumanities and Social Sciences…2023

    Human genome editing technologies are advancing at a rapid pace, and their potential disruptive implications lead to ethical and societal questions that cannot be addressed by scientists alone. Further consideration of different stakeholders’ views on human genome editing is crucial to translate society’s needs and values into thoughtful regulations and policies. We therefore explored the views of carriers of autosomal dominant disorders on somat…

  • Neonatal and carrier screening for rare diseases

    Open AccessMartina C Cornel, Tessel Rigter et al.ARTICLEJournal of Community Genetics2020

    Screening for rare diseases first began more than 50 years ago with neonatal bloodspot screening (NBS) for phenylketonuria, and carrier screening for Tay-Sachs disease, sickle cell anaemia and β-thalassaemia. NBS's primary aim is health gain for children, while carrier screening enables autonomous reproductive choice. While screening can be beneficial, it also has the potential to cause harm and thus decisions are needed on whether a specific scr…

  • Direct-to-consumer carrier screening for cystic fibrosis via a hospital website

    Open AccessKim C A Holtkamp, Lidewij Henneman et al.ARTICLEJournal of Community Genetics2018

    A Dutch university hospital started offering cystic fibrosis (CF) carrier screening directly to consumers (DTC) through their website in 2010. A 6-year process evaluation was conducted to evaluate the offer. Screening was implemented as intended. However, uptake was lower than expected. Forty-four tests have been requested, partly by couples with a positive family history for CF, which was not the intended target group. Users were generally posit…

  • Genomics for all in the 21st century

    Open AccessMartina C Cornel, Vence L BonhamARTICLEJournal of Community Genetics2017

    As the field of genomics enters the second decade after the completion of the International Human Genome Project, human genomics research is still far from reflective of the ancestral diversity found in global populations. This special issue of the Journal of Community Genetics brings together a global perspective on the need for researchers and health care professionals to support achievable milestones that will enhance global ancestral diversit…

  • Blame—a novel by Tony Holtzman

    Open AccessMartina C CornelARTICLEJournal of Community Genetics2017

    After writing many scientific articles at the interface of genetics and society, Neil A (Tony) Holtzman published a novel in Autumn 2016: Blame. This book review summarizes several of the story lines, some of which are related to the Inclusion of Diverse Populations in Genomics Research and Health Services, the topic of a special issue of the Journal of Community Genetics

  • The challenges of the expanded availability of genomic information

    Open AccessPascal Borry, Heidi Beate Bentzen et al.ARTICLEJournal of Community Genetics2017

    Rapid advances in microarray and sequencing technologies are making genotyping and genome sequencing more affordable and readily available. There is an expectation that genomic sequencing technologies improve personalized diagnosis and personalized drug therapy. Concurrently, provision of direct-to-consumer genetic testing by commercial providers has enabled individuals' direct access to their genomic data. The expanded availability of genomic da…

  • Implementing genetic education in primary care

    Open AccessMilena Paneque, Martina C Cornel et al.ARTICLEJournal of Community Genetics2017

  • Effects of a simple educational intervention in well-baby clinics on women’s knowledge about and intake of folic acid supplements in the periconceptional period

    Open AccessDenhard J de Smit, Stephanie S Weinreich et al.ARTICLEPublic Health Nutrition2015

    Objective To test the hypothesis that a concise intervention to promote the preconception use of folic acid (FA) supplements among mothers who visit a well-baby clinic (WBC) for the 6-month check-up of their youngest child is effective. Effectiveness was measured as intention to use or actual use of FA supplements before a next pregnancy among women who expected to be pregnant within 0–12 months. Design Controlled intervention study with independ…

  • Developing a framework for implementation of genetic services

    Open AccessTessel Rigter, Lidewij Henneman et al.ARTICLEJournal of Community Genetics2014

  • The Dutch national summit on preconception care

    Open AccessSevilay Temel, Sabine F Van Voorst et al.ARTICLEJournal of Community Genetics2014

  • Factors associated with not using folic acid supplements preconceptionally

    Open AccessJudith Manniën, Ank de Jonge et al.ARTICLEPublic Health Nutrition2014

    Objective Neural tube defects are among the most common birth defects worldwide. Folic acid intake from one month before to three months after conception reduces the likelihood of neural tube defects by at least 50 %. Since 1995, several campaigns have been organised in the Netherlands which resulted in 51 % of pregnant women using folic acid supplements during the entire recommended period in the northern part of the Netherlands in 2005. Our res…

  • Illness representations of type 2 diabetes patients are associated with perceptions of diabetes threat in relatives

    Open AccessSuzanne Cm Van Esch, Marjan D Nijkamp et al.ARTICLEJournal of Health Psychology2014Cited by: 4References: 34

    In the fight against the type 2 diabetes epidemic, patients might be asked to discuss familial susceptibility to type 2 diabetes in their family. Illness representations of patients ( N = 546) were assessed to explore their impact on perceived type 2 diabetes threat in relatives. Reporting high type 2 diabetes burden, emotional impact and perceiving type 2 diabetes as an inheritable disease seemed to increase patients' family risk perception and …

  • Using web-based familial risk information for diabetes prevention

    Open AccessMiranda Wijdenes, Lidewij Henneman et al.ARTICLEBMC Public Health2013

    NTR1938

  • The challenge of implementing genetic tests with clinical utility while avoiding unsound applications

    Open AccessMartina C Cornel, Carla van El et al.ARTICLEJournal of Community Genetics2012

  • The Politics of Representation in the Governance of Emergent 'Secondary Use' Biobanks

    Conor M W Douglas, Carla van El et al.ARTICLEStudies in Ethics Law and…2012Cited by: 1References: 3

    There is an international discussion to transform the collection of dried blood spot (DBS) card collections resulting from neonatal public health screening programs into a kind of biobank through the formalization of their (prolonged) retention and by expanding their use in medical research and development (R&D) practices. Given the scale of neonatal heel prick screening, these blood samples are increasingly being considered as a wealth of biolog…

  • The promises of genomic screening

    Open AccessMartina C Cornel, Carla van El et al.ARTICLEJournal of Community Genetics2011

    New screening possibilities become available at a high rate, both useful and unsound possibilities. All screening programmes do harm, and only few have more advantages than disadvantages at reasonable cost. Horizon scanning is needed to identify those few possibilities with more pros than cons. Attunement is needed between actors involved: scientists developing new high-throughput screening techniques and treatment, health care workers, patients …

  • Connective tissue

    Open AccessEric Vermeulen, Marjanka K Schmidt et al.ARTICLEBioSocieties2011

  • Genetic screening and democracy

    Open AccessCarla Geertruida van El, Toine Pieters et al.ARTICLEJournal of Community Genetics2011

    Recent decades have witnessed increasing possibilities for genetic testing and screening. In clinical genetics, the doctor's office defined a secluded space for discussion of sensitive reproductive options in cases of elevated risk for genetic disorders in individuals or their offspring. When prenatal screening for all pregnant women became conceivable, the potential increase in scale made social and ethical concerns relevant for the whole of soc…

  • Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment

    Open AccessMiranda Wijdenes-Pijl, Wybo Dondorp et al.ARTICLEBMC Public Health2011

    The results suggest that most participants believe a predictive genetic test could be used in the prevention of multifactorial disorders, such as diabetes, but indicate points to consider before both these tests are applied. These considerations differ with regard to the method of assessment (DNA test or obtaining family history) and also differ from monogenic disorders

  • Validation of self-reported folic acid use in a multiethnic population

    Open AccessJonne J Sikkens, Manon van Eijsden et al.ARTICLEPublic Health Nutrition2011

    Objective To assess folic acid supplementation rates and validate the self-reporting of folic acid supplement use among pregnant women in a multiethnic cohort. Design Secondary analysis of a prospective cohort study. Setting Self-reported folic acid supplement use in the Amsterdam Born Children and their Development study cohort was compared with serum folate concentrations using non-parametric trend analysis and linear and logistic regression. S…

  • A case study of haemoglobinopathy screening in the Netherlands

    Suze Jans, Suze M P J Jans et al.ARTICLEEthnicity and Health2011Cited by: 1References: 1

    Carrier screening in general never appeared high on the policy agenda. Registration of ethnicity remains sensitive caused by the current political climate. Complexities related to carrier screening are a challenge in Dutch healthcare. Whether carrier screening will be considered a valuable complementary strategy in the Netherlands, depends partly on participation of representatives of high-risk groups in policy making